Skip to main content

Market Overview

20 Biggest Mid-Day Losers For Friday

  • CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
  • Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
  • The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
  • Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
  • Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
  • Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
  • AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
  • Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 million.
  • TOP SHIPS Inc (NASDAQ: TOPS) shares fell 14.1 percent to $1.89 after surging 109.52 percent on Thursday.
  • Caleres Inc (NYSE: CAL) shares dropped 12.8 percent to $27.59 after the company posted weaker-than-expected earnings for its fourth quarter.
  • Exa Corp (NASDAQ: EXA) declined 12.8 percent to $13.68. Exa reported Q4 adjusted earnings of $0.05 per share on revenue of $19.5 million. Canaccord Genuity downgraded Exa from Buy to Hold.
  • Veritiv Corp (NYSE: VRTV) shares dropped 11.7 percent to $51.95. Veritiv priced its 1.8 million share secondary offering of common stock at $54.85 per share.
  • AXT Inc (NASDAQ: AXTI) declined 10.6 percent to $5.90 after dropping 10.81 percent on Thursday. B. Riley downgraded AXT from Buy to Neutral.
  • GSV Capital Corp (NASDAQ: GSVC) fell 10.1 percent to $4.81. GSV Capital reported a Q4 loss of $31.5 million.
  • Cerulean Pharma Inc (NASDAQ: CERU) shares declined 8.4 percent to $2.82 after rising 3.36 percent on Thursday.
  • Vuzix Corporation (NASDAQ: VUZI) shares fell 7.7 percent to $6.64 after the company issued a business update and reported Q4 financial results.
  • Editas Medicine Inc (NASDAQ: EDIT) dropped 7.5 percent to $23.04. Editas Medicine priced an underwritten offering of 4,000,000 shares at $22.50 per share.
  • Diana Containerships Inc (NASDAQ: DCIX) fell 5.1 percent to $2.64 after surging 12.55 percent on Thursday.
  • Ocular Therapeutix Inc (NASDAQ: OCUL) fell 4.5 percent to $9.53 after gaining 12.13 percent on Thursday.
  • Inventure Foods Inc (NASDAQ: SNAK) fell 3 percent to $4.89 after the company filed to delay its Annual Report on Form 10-K for fiscal 2016.

Latest Ratings for CRMD

Feb 2021NeedhamInitiates Coverage OnBuy
Feb 2021Truist SecuritiesMaintainsBuy
Sep 2020JMP SecuritiesInitiates Coverage OnMarket Outperform

View More Analyst Ratings for CRMD
View the Latest Analyst Ratings


Related Articles (CRMD + BIOA)

View Comments and Join the Discussion!

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

Latest Ratings

PBTruist SecuritiesMaintains88.0
CFRTruist SecuritiesMaintains111.0
FANGTruist SecuritiesMaintains105.0
SBNYCredit SuisseMaintains250.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at